# So far in 2026, there have been 79 IPO filings in the United States, with 41 pricings of at least $50 million in market cap.

*fintech · news · 2026-04-24 · Morningstar*

## Key points

- The majority of 2026 US IPO filings have come from biotech and non-tech sectors, not tech startups.
- SpaceX's anticipated summer IPO is considered potentially the largest in history by exit value.
- Smaller issuers are rushing to go public before the SpaceX IPO potentially dominates investor attention.
- Top VC-backed tech firms are holding back IPO plans due to high valuations and weak post-IPO performance.
- Biotech and mature PE-backed companies are leading IPO activity while major tech firms remain sidelined.

**Companies:** SpaceX, Amazon, Kailera Therapeutics, Odyssey Therapeutics, Mobia Medical, X-Energy
**Countries:** United States

[Read the full story on Morningstar](https://www.morningstar.com/markets/biotech-healthcare-companies-drive-ipo-resurgence)

---

Canonical: https://newsio.io/n/1a75eb06-cda7-4801-8397-53352f796c1e/so-far-in-2026-there-have-been-79-ipo-filings-in-the-united-states-with-41-prici
Summarized by Newsio from Morningstar. https://newsio.io/how-it-works